Argos Therapeutics Inc fka ARGSQ

[jeffyh]

NWBO is a radiant diamond hidden in the pile of useless rocks. However, few people seem to have find out that it has a tremendous potential and inestimable value. After all, NWBO dropped to a dirt cheap price, plummeting from the heaven to the hell. Now what? Is this the end? Will it be there any chance for NWBO to fly back to heaven? Of course it depends on whether or not DCVAX-L has real value, in other words 'Efficacy of the Medicine'

In fact, it's not easy to find out a real pearl in the mud flat. We are not always able to see it. Ones can figure out its inestimable value while others not. If DCVAX-L phase III trial result were good enough to get approved by FDA, DCVAX-L would open a new chapter for the immunotherapy of cancer. As you know, the chemotherapy has been also improved a lot, but still faces a dilemma that It kills blue forces as well as enemy forces. It is the very DCVAX-L's success that opens the new door to solve the dilemma those chemotherapies face. Besides, it will spark a chain reaction once it is approved and its explosive power will be like a nuclear bomb, I guess.

It is said that one of the best favourable factor in the stock market must be 'the bargain price'. It is time to buy NWBO, the bright pearl still shining in the mud flat, when most of investors turn their face away from the invaluable jewel. In October 2008, KERX became a so-called garbage whose price was only a dime, but KERX jumped over the moon and its price became around $18 in August 2014. What about JAZZ? In April 2009, JAZZ was only $0.5. Now you know how much it is. Don't you think now next blockbuster will probably be NWBO?